Fisher And Paykel Healthcare Corpo dividend and valuation
Valuation
Fisher And Paykel Healthcare Corpo paid $0.44 per share in dividends over the last 12 months (yield 1.1%). Last ex-dividend date: June 22, 2026. The P/E ratio is 57.7. The average price target of 8 analysts is $39.51.
Data as of November 22, 2026
Fisher And Paykel Healthcare Corpo compared with similar companies
Fisher And Paykel Healthcare Corpo's P/E (trailing 12 months): 57.7, +38% against the median of a group of 10 similar companies (41.9).
| Metric | Fisher And Paykel Healthcare Corpo | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 57.7 | 41.9 | 23.5 – 67.6 | Middle |
| Forward P/E | 45.6 | 18.8 | 15.4 – 33.8 | High |
| EV/EBITDA | 30.8 | 18.6 | 15.4 – 22.4 | High |
| Price/book | 13.8 | 5.71 | 2.31 – 7.74 | High |
| Price/sales | 10.3 | 4.22 | 2.83 – 8.11 | High |
| Gross margin | 63.7% | 61.8% | 49.6% – 66.2% | Middle |
| Operating margin | 27.6% | 17.8% | 11.7% – 26.7% | High |
| Net margin | 20.3% | 10.6% | 6.7% – 17.1% | High |
| ROE | 23.4% | 10.5% | 7.3% – 21.8% | High |
| Debt/equity | 0.07 | 0.37 | 0.16 – 1.02 | Low |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Other metrics
Valuation multiples
- Market cap
- $23.78B
- Enterprise value
- $23.41B
- PEG
- 43.6
- EV/revenue
- 10.1
Profitability and growth
- ROA
- 14.7%
- ROIC
- 18.5%
- Revenue growth (year over year)
- 14.0%
- Earnings growth (year over year)
- 14.3%
Financial health
- Total cash
- $461.1M
- Total debt
- $146.1M
- Current ratio
- 2.32
- Quick ratio
- 1.62
Dividends
- Annual dividend per share
- $0.44
- Dividend yield
- 1.1%
- Payout ratio
- 54.2%
- Ex-dividend date
- June 22, 2026
Analysts and estimates
- Average price target
- $39.51
- Median price target
- $40.00
- High price target
- $47.32
- Low price target
- $26.20
- Analysts with a price target
- 8
- Forward EPS
- $0.89
- EPS estimate, current year
- $0.94
Shares and trading
- Beta
- 0.93
- Average volume
- 478.21K
- Shares outstanding
- 588.27M
- Float
- 584.75M
- Institutional ownership
- 38.9%
- Insider ownership
- 3.7%
